Searchable abstracts of presentations at key conferences in endocrinology

ea0059p112 | Neoplasia, cancer & late effects | SFEBES2018

Use of glucocorticoids following immunotherapy for cancer

Agarwal Kapil , Yousaf Nadia , Morganstein Daniel

Background: Immune checkpoint inhibitors have demonstrated significant advances in the treatment of several cancers including metastatic melanoma. However, they are frequently associated with immune-related adverse events which often require treatment with prolonged courses of glucocorticoids. Long-term glucocorticoid use is associated with several side effects including hyperglycaemia.Aims: 1) To determine the prevalence of glucocorticoid use in patien...